+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Corporate Governance Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Corporate Governance Trends in Healthcare - Thematic Intelligence

  • Report
  • February 2023
  • 55 Pages
  • Global
From
Environmental Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Environmental Trends in Healthcare - Thematic Intelligence

  • Report
  • January 2023
  • 57 Pages
  • Global
From
Italian Distribution Market - Healthcare Logistics Contracts - Product Thumbnail Image

Italian Distribution Market - Healthcare Logistics Contracts

  • Report
  • September 2021
  • 28 Pages
  • Italy
From
Italian Distribution Market - Healthcare Logistics Contracts, Leading Players and Compliance - Product Thumbnail Image

Italian Distribution Market - Healthcare Logistics Contracts, Leading Players and Compliance

  • Report
  • September 2021
  • 60 Pages
  • Italy
From
Italian Distribution Market - Healthcare and Medical Devices Logistics Contracts - Product Thumbnail Image

Italian Distribution Market - Healthcare and Medical Devices Logistics Contracts

  • Report
  • September 2021
  • 34 Pages
  • Italy
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Biogen - Product Thumbnail Image

Biogen

  • Company Profile
  • July 2020
  • 41 Pages
Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2024
  • 75 Pages
From
Biogen Idec Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Biogen Idec Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Biogen 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Biogen 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • December 2023
  • Global
From
Biogen, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Biogen, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • December 2023
  • 47 Pages
From
2022 Biogen Half-Year Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

2022 Biogen Half-Year Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • June 2022
  • Global
From
Loading Indicator